• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
CRO Industry Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs Now Available
 

CRO Industry Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs Now Available

on

  • 184 views

ReportsnReports.com adds “PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs” research report to its store.

ReportsnReports.com adds “PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs” research report to its store.

Statistics

Views

Total Views
184
Views on SlideShare
184
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    CRO Industry Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs Now Available CRO Industry Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs Now Available Document Transcript

    • © ReportsnReports.com / Contact sales@reportsandreports.com PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs ReportsnReports.com adds “PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs” research report to its store. The CRO Benchmark Report applies a proprietary ranking methodology to compare the competitive positions of 11 leading CRO companies on 17 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders. Throughout the report, the reader is provided with expert insights, expanding on each of the metrics discussed. In addition to the financial metrics, this report discusses trends impacting the CRO marketplace, along with partnering and acquisition activity, and operations strategy. This report also provides drill-down analyses of three service lines and four geographies examining each of these segment’s revenue and growth leaders, and business development strategies. Lastly, this report provides the publisher’s outlook on the CRO sector and each company’s future competitive position. PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs ( http://www.reportsnreports.com/reports/267582-pharmaleaders-cro- benchmark-report-financial-benchmarking-competitive-landscape-assessment-of-leading-cros.html ) provides analysis of the key drivers and trends shaping the global CRO market including biologics manufacturing, emerging markets and eClinical technologies, A deep dive into the synergies behind partnering and acquisition activity, Discussion of business line and regional segment strategies, Assessments of company financials by revenue, margin, expense and capital structure, Firm utilization, resources management, and efficiency metrics as well as information on Leadership / management changes. BRICs and Other Emerging Regions Represent Huge Untapped Markets for Clinical R&D With lower overall costs, better recruitment and retention rates, strong investigator networks and populations in need of novel treatments, conducting studies in the emerging markets is a strategic necessity. Biopharmaceutical companies with less experience in conducting trials in the emerging markets may need on-the-ground expertise to ensure their project is tailored to local patients and complies with regional regulations. Other drug makers that already have the experience in the region may need operational support or advice on how to ensure locally conducted trials satisfy the needs of global regulatory bodies, to mitigate costly clinical trial disruptions. CROs with the ability to deliver cost and time-saving efficiencies to clients without compromising patient safety and data quality will be able to yield higher returns from emerging markets.
    • © ReportsnReports.com / Contact sales@reportsandreports.com Order a copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=267582 . Companies listed in this report: Accelovance, Accovion, AMRI, Aptuit, Asklep, BioRasi, Catalent, Charles River, Chiltern, Clinipace, ClinStar, CMIC, Covance, CromSource, DKSH, EPS Corporation, Frontage, Icon, INC Research, Novella Clinical, Novotech, Ockham, Octagon Research Solutions, Paragon Biomedical, Parexel, Patheon, Pharmaron, Pharm-Olam, PPD, PRA International, PSI, QPS, Quintiles, ReSearch Pharmaceutical Services, Synexus, Syngene, SynteractHCR, TFS International and WuXi. Complete report PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs available at http://www.reportsnreports.com/reports/267582- pharmaleaders-cro-benchmark-report-financial-benchmarking-competitive-landscape-assessment-of- leading-cros.html . You may also be interested in similar other reports available with us: PharmaLeaders: Top 10 Pharmaceutical Companies in India Benchmark Report - Competitive Analysis of the Leading Players in 2013 at http://www.reportsnreports.com/reports/267434-pharmaleaders- top-10-pharmaceutical-companies-in-india-benchmark-report-competitive-analysis-of-the-leading- players-in-2013.html . PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013 at http://www.reportsnreports.com/reports/232728- pharmaleaders-generic-manufacturers-benchmark-report-financial-benchmarking-competitive- analysis-of-the-leading-generic-players-in-2013.html .